Fights inflammation and oxidative stress
NAC is the precursor to glutathione, a powerful antioxidant, which helps to scavenge free radicals and reactive oxygen species (ROS) that causes cell damage. It reduces oxidative stress and inflammation - especially beneficial if you have PCOS.*
Improves insulin sensitivity
Insulin resistance is linked to the cardiometabolic and reproductive disorders in PCOS. NAC has insulin-sensitizing properties which improves your body’s insulin receptor activity, helping you lower insulin levels to keep PCOS symptoms at bay.
Supports and boosts fertility
Because of its potent antioxidant and insulin-sensitizing effects, NAC can help prevent endothelial damage, improve ovulation, and regulate menstrual cycles to support your overall reproductive health. NAC also has potential to improve pregnancy and live birth rates in women with PCOS.
Take 1 capsule, 1-2 times daily, between meals, or as directed by a physician.
Do not exceed recommended dose. Pregnant and nursing mothers, children under the age of 18, and individuals with a known medical condition or taking prescription medication should consult a physician before taking this or any dietary supplement.
 Queiroz de Andrade, K., Moura, F. A., Marques dos Santos, J., Pimentel de Araujo, O. R., Celia de Farias Santos, J., & Fonseca Goulart, M. O. (2015). Oxidative stress and inflammation in hepatic diseases: Therapeutic possibilities of n-acetylcysteine. International Journal of Molecular Sciences, 16(12), 30269-30308. DOI: 10.3390/ijms161226225
 Pei, Y., Liu, H., Yang, Y., Jiao, Y., Tay, F. R., & Chen, J. (2018). Biological activities and potential oral applications of n-acetylcysteine: Progress and prospects. Oxidative Medicine and Cellular Longevity, 1-14. DOI: 10.1155/2018/2835787
 Thorne Research, Inc. (2000). N-acetylcysteine. Alternative Medicine Review, 5(5), 467-471. https://www.ncbi.nlm.nih.gov/pubmed/11056417.
 Mokhtari, V., Afsharian, P., Shahhoseini, M., Kalantar, S. M., & Moini, A. (2017). A review on various uses of n-acetyl cysteine. Cell Journal, 19(1), 11-17. DOI: 10.22074/cellj.2016.4872
 Tse, H. N., & Steven Tseng, C. Z. (2014). Update on the pathological processes, molecular biology, and clinical utility of n-acetylcysteine in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 9, 825-836. DOI: 10.2147/COPD.S51057
 Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018). N-acetylcysteine as an antioxidant and disulphide breaking agent: The reasons why. Free Radical Research, 52(7), 751-762. DOI: https://doi.org/10.1080/10715762.2018.1468564
 Ooi, S., Green, R., & Pak, S. (2018). N-acetylcysteine for the treatment of psychiatric disorders: A review of current evidence. BioMed Research International, 1-8. DOI: 10.1155/2018/2469486
 Santus, P., Corsico, A., Solidoro, P., Braido, F., Di Marco, F., & Scichilone, N. (2014). Oxidative stress and respiratory system: Pharmacological and clinical reappraisal of n-acetylcysteine. COPD, 11(6), 705-717. DOI: 10.3109/15412555.2014.898040
 Shahripour, R. B., Harrigan, M. R., & Alexandrov, A. V. (2014). N-acetylcysteine (NAC) in neurological disorders: Mechanisms of action and therapeutic opportunities. Brain and Behavior, 4(2), 108-122. DOI: 10.1002/brb3.208
 McClure, E. A., Gipson, C. D., Malcolm, R. J., Kalivas, P. W., & Gray, K. M. (2014). Potential role of n-acetylcysteine in the management of substance use disorders. CNS Drugs, 28(2), 95-106. DOI: 10.1007/s40263-014-0142-x
 Tardiolo, G., Bramanti, P., & Mazzon, E. (2018). Overview on the effects of n-acetylcysteine in neurodegenerative diseases. Molecules, 23(12), 1-20. DOI: 10.3390/molecules23123305